The U.S. Court of Appeals for the Second Circuit approved a provision in the Purdue Pharma bankruptcy settlement this week that shields the Sackler family from liability for opioid deaths,  and experts say the court's analysis will be cited as support for other potentially controversial tools or strategies used by businesses filing Chapter 11.